Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part A
Series: International Review of Cell and Molecular Biology; 381;
- Publisher's listprice EUR 171.00
-
70 922 Ft (67 545 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 14 184 Ft off)
- Discounted price 56 738 Ft (54 036 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
70 922 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 19 September 2023
- ISBN 9780443161346
- Binding Hardback
- No. of pages174 pages
- Size 228x152 mm
- Weight 410 g
- Language English 497
Categories
Long description:
"
""Circulating Tumor Cells, from biotech innovation to clinical utility"" provides an overview of the most recent technological and clinical advances with regards to the study of circulating tumor cells (CTCs) in solid tumors. The volumes cover studies on CTCs in breast, prostate, colorectal and lung cancer, with a focus on clinical utility, and also include methodological and biological topics such as CTC culture, multi-omic characterization of CTCs, atypical CTC populations and interaction between CTCs and immunity.
" MoreTable of Contents:
1. Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer
Laura S. Munoz-Arcos, Eleonora Nicolï¿1⁄2, Mara S. Serafini, Lorenzo Gerratana, Carolina Reduzzi, and Massimo Cristofanilli
2. Can we define breast cancer HER2 status of by liquid biopsy?
Serena Di Cosimo, Cinzia De Marco, Marco Silvestri, Adele Busico, Andrea Vingiani, Giancarlo Pruneri, and Vera Cappelletti
3. Models to study CTCs and CTC culture methods
Cristï¿1⁄2bal Fernï¿1⁄2ndez-Santiago, Rafael Lï¿1⁄2pez-Lï¿1⁄2pez, and Roberto Piï¿1⁄2eiro Cid
4. Settling the uncertainty about unconventional circulating tumor cells: epithelial-to-mesenchymal transition, cell fusion and trogocytosis
Giulia Gallerani, Tania Rossi, Manuela Ferracin, and Massimiliano Bonafï¿1⁄2
5. Circulating tumor cells in cancer-risk populations as a cancer interception tool
Marï¿1⁄2a Josï¿1⁄2 Serrano, Christian Rolfo, Josï¿1⁄2 Expï¿1⁄2sito-Hernandez, Carmen Garrido-Navas, Josï¿1⁄2 Javier Lopez-Hidalgo, and Valeria Denninghoff
6. Circulating tumor cells and host immunity: a tricky liaison
Elena Muraro and Giulia Brisotto
Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas: Molecular Genetics: Liver and Pancreatic Carcinomas V3
89 171 HUF
80 254 HUF
